Compounds > diosgenin
Page last updated: 2024-08-26

diosgenin and Mouth Neoplasms

diosgenin has been researched along with Mouth Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Hu, H; Li, XL; Liu, HH; Liu, JG; Ran, YH; Ren, QL; Song, ZX; Tang, JJ; Wang, M; Wang, Q; Yang, XT; Zhang, XQ1
Chen, X; Fu, X; Gu, W; Tian, H; Wang, Y; Wen, Y; Zhang, Y1
Chen, JC; Chen, MK; Chien, SY; Chuang, YC; Hsi, YT; Hsieh, MJ; Lin, CC; Lin, CW; Lo, YS; Yang, SF1
López Jornet, P; Pons-Fuster López, E; Wang, QT; Wei, W1
Chen, Q; Guo, X; He, S; Ji, N; Jiang, L; Li, J; Lin, Y; Sun, C; Wang, X; Xu, H; Ye, L; Zeng, X; Zhou, Y1
Arokia Vijayaanand, M; Kalaimathi, J; Rajalingam, K; Sugunadevi, G; Suresh, K1

Reviews

1 review(s) available for diosgenin and Mouth Neoplasms

ArticleYear
Anticancer Activity of Diosgenin and Its Molecular Mechanism.
    Chinese journal of integrative medicine, 2023, Volume: 29, Issue:8

    Topics: Apoptosis; Carcinoma, Squamous Cell; Diosgenin; Humans; Male; Mouth Neoplasms; Prostatic Neoplasms

2023

Other Studies

5 other study(ies) available for diosgenin and Mouth Neoplasms

ArticleYear
Dioscin inhibits SCC15 cell proliferation via the RASSF1A/MST2/YAP axis.
    Molecular medicine reports, 2021, Volume: 23, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Diosgenin; Humans; Mouth Neoplasms; Protein Serine-Threonine Kinases; Serine-Threonine Kinase 3; Transcription Factors; Tumor Suppressor Proteins; YAP-Signaling Proteins

2021
Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways.
    Scientific reports, 2017, 03-22, Volume: 7

    Topics: Apoptosis; Autophagy; Cathepsins; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Survival; Diosgenin; Humans; MAP Kinase Signaling System; Mouth Neoplasms; Saponins

2017
Potential chemotherapeutic effects of diosgenin, zoledronic acid and epigallocatechin-3-gallate on PE/CA-PJ15 oral squamous cancer cell line.
    Archives of oral biology, 2017, Volume: 82

    Topics: Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Diosgenin; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Imidazoles; Mouth Neoplasms; Zoledronic Acid

2017
Apoptotic effects of diosgeninlactoside on oral squamous carcinoma cells in vitro and in vivo.
    Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:9

    Topics: Animals; Antineoplastic Agents; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Squamous Cell; Caspases; Cell Line; Cell Line, Tumor; Cell Survival; Diosgenin; Female; Glycosides; Humans; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mouth Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tumor Burden

2014
Anti-tumour and anti-oxidative potential of diosgenin against 7, 12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis.
    Pathology oncology research : POR, 2012, Volume: 18, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Carcinoma, Squamous Cell; Cricetinae; Diosgenin; Lipid Peroxidation; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Thiobarbituric Acid Reactive Substances

2012